Page last updated: 2024-12-06

n-(8-aminohexyl)-5-iodonaphthalene-1-sulfonamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(8-aminohexyl)-5-iodonaphthalene-1-sulfonamide: calmodulin antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID59789
MeSH IDM0178882

Synonyms (9)

Synonym
n-(6-aminohexyl)-5-iodo-1-naphthalenesulfonamide
n-(8-aminohexyl)-5-iodonaphthalene-1-sulfonamide
1-naphthalenesulfonamide, n-(6-aminohexyl)-5-iodo-
n-(6-aminohexyl)-5-iodonaphthalene-1-sulfonamide
5-iodo-c8
iodo-8
5-iodo-1-c8
103771-11-5
DTXSID50146048

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Adverse events were prospectively collected for safety assessment during the follow-up."( Sacral neuromodulation for refractory ulcerative colitis: safety and efficacy in a prospective observational series of eight patients.
Bourreille, A; Drissi, F; Meurette, G; Neunlist, M, 2023
)
0.91
"SNM application is safe in patients suffering from refractory UC."( Sacral neuromodulation for refractory ulcerative colitis: safety and efficacy in a prospective observational series of eight patients.
Bourreille, A; Drissi, F; Meurette, G; Neunlist, M, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (46.67)18.2507
2000's0 (0.00)29.6817
2010's1 (6.67)24.3611
2020's7 (46.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.84 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.67 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (6.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (6.67%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]